Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Laporte

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Neuromuscular Disorders : NMD|May 18, 2004
118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy)E Bertini, V Biancalana, A Bolino, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2025
Automated Iterative N─C and C─C Bond FormationTheodore Tyrikos-Ergas, Sevasti Agiakloglou, Antonio J LaPorte, et al.
Trials|May 20, 2020
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)J Laporte-Amargos, C Gudiol, M Arnan, et al.
Human Molecular Genetics|September 1, 1996
Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4Y J de Kok, E R Vossenaar, C W Cremers, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)A Albasanz-Puig, C Gudiol, P Puerta-Alcalde, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosaC Gudiol, A Albasanz-Puig, J Laporte-Amargós, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Neuromuscular Disorders : NMD|May 18, 2004
118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy)E Bertini, V Biancalana, A Bolino, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2025
Automated Iterative N─C and C─C Bond FormationTheodore Tyrikos-Ergas, Sevasti Agiakloglou, Antonio J LaPorte, et al.
Trials|May 20, 2020
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)J Laporte-Amargos, C Gudiol, M Arnan, et al.
Human Molecular Genetics|September 1, 1996
Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4Y J de Kok, E R Vossenaar, C W Cremers, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study)A Albasanz-Puig, C Gudiol, P Puerta-Alcalde, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosaC Gudiol, A Albasanz-Puig, J Laporte-Amargós, et al.
Pageof 17